Contemporary management of penile squamous cell carcinoma

Journal of Surgical Oncology

Volumn 89, Issue 1, 2005, Pages 43-50

  Kroon, Bin K ^a   Horenblas, Simon ^a   Nieweg, Omgo E ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Lymphadenectomy; Penile neoplasms; Penis; Sentinel lymph node biopsy; Urologic cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; VINCRISTINE;

CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; FOLLOW UP; HUMAN; INGUINAL REGION; LASER SURGERY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; PENILE BIOPSY; PENIS AMPUTATION; PENIS CARCINOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; ULTRASOUND;

AGED; CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PENILE NEOPLASMS; SURVIVAL ANALYSIS;

EID: 11344279980     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20170     Document Type: Review

References (78)

1. Landis SH, Murray T, Bolden S, et al.: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31, 1.
2. Frisch M, Friis S, Kjaer SK, et al.: Falling incidence of penis cancer in an uncircumcised population (Denmark 1943-90). BMJ 1995;311:1471.
3. Persky L: Epidemiology of cancer of the penis. Recent Results Cancer Res 1977;60:97-109.
4. Indian Council of Medical Research (ICMR): National Cancer Registry Program. Consolidated Report of the Population based cancer registries 1990-1996. New Delhi: ICMR Publication; 2001. pp 114-224.
5. Ornellas AA, Seixas AL, Marota A, et al.: Surgical treatment of invasive squamous cell carcinoma of the penis: Retrospective analysis of 350 cases. J Urol 1994;151:1244-1249.
6. Dillner J, von Krogh G, Horenblas S, et al.: Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 2000;205:189-193.
7. Reddy DG, Baruah IK: Carcinogenic action of human smegma. Arch Pathol 1963;75:414-420.
8. Moses S, Bailey RC, Ronald AR: Male circumcision: Assessment of health benefits and risks. Sex Transm Infect 1998;74:368-373.
9. Griffiths TR, Mellon JK: Human papillomavirus and urological tumours: I. Basic science and role in penile cancer. BJU Int 1999;84:579-586.
10. Harish K, Ravi R: The role of tobacco in penile carcinoma. Br J Urol 1995;75:375-377.
11. Burgers JK, Badalament RA, Drago JR: Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am 1992;19:247-256.
12. Horenblas S, Kroger R, Gallee MP, et al.: Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology 1994;43:702-707.
13. Lont AP, Besnard AP, Gallee MP, et al.: A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 2003;91:493-495.
14. Horenblas S: Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: Diagnosis of lymph node metastasis. BJU Int 2001;88:467-472.
15. Senthil Kumar MP, Ananthakrishnan N, Prema V. Predicting regional lymph node metastasis in carcinoma of the penis: A comparison between fine-needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy. Br J Urol 1998;81:453-457.
16. Horenblas S, Van Tinteren H, Delemarre JF, et al.: Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 1991;146:1279-1283.
17. Abi-Aad AS, deKernion JB: Controversies in ilioinguinal lymphadenectomy for cancer of the penis. Urol Clin North Am 1992;19:319-324.
18. Horenblas S, Van Tinteren H, Delemarre JF, et al.: Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 1993;149:492-497.
19. International Union Against Cancer. Penis. In: Hermanek P, Sobin LH, editors. TNM classification of malignant tumours, 4th edn. Berlin, Heidelberg: Springer Verlag; 1987.
20. McDougal WS, Kirchner FK, Jr., Edwards RH, et al.: Treatment of carcinoma of the penis: The case for primary lymphadenectomy. J Urol 1986;136:38-41.
21. Windahl T, Hellsten S: Laser treatment of localized squamous cell carcinoma of the penis. J Urol 1995;154:1020-1023.
22. Horenblas S, Van Tinteren H, Delemarre JF, et al.: Squamous cell carcinoma of the penis. II. Treatment of the primary tumor. J Urol 1992;147:1533-1538.
23. McLean M, Akl AM, Warde P, et al.: The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 1993;25:623-628.
24. Ravi R, Chaturvedi HK, Sastry DV: Role of radiation therapy in the treatment of carcinoma of the penis. Br J Urol 1994;74:646-651.
25. Gerbaulet A, Lambin P: Radiation therapy of cancer of the penis. Indications, advantages, and pitfalls. Urol Clin North Am 1992;19:325-332.
26. Cabañas RM: Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am 1992;19:267-276.
27. Crawford ED, Daneshgari F: Management of regional lymphatic drainage in carcinoma of the penis. Urol Clin North Am 1992;19:305-317.
28. Dewire D, Lepor H: Anatomic considerations of the penis and its lymphatic drainage. Urol Clin North Am 1992;19:211-219.
29. Valdés Olmos RA, Tanis PJ, Hoefnagel CA, et al.: Penile lymphoscintigraphy for sentinel node identification. Eur J Nucl Med 2001;28:581-585.
30. Lopes A, Hidalgo GS, Kowalski LP, et al.: Prognostic factors in carcinoma of the penis: Multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996;156:1637-1642.
31. Brkovic D, Kalble T, Dorsam J, et al.: Surgical treatment of invasive penile cancer - The Heidelberg experience from 1968 to 1994. Eur Urol 1997;31:339-342.
32. Ayyappan K, Ananthakrishnan N, Sankaran V: Can regional lymph node involvement be predicted in patients with carcinoma of the penis? Br J Urol 1994;73:549-553.
33. Srinivas V, Morse MJ, Herr HW, et al.: Penile cancer: Relation of extent of nodal metastasis to survival. J Urol 1987;137:880-882.
34. Ravi R: Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 1993;72:817-819.
35. Ravi R: Prophylactic lymphadenectomy versus observation versus inguinal biopsy in node-negative patients with invasive carcinoma of the penis. Jpn J Clin Oncol 1993;23:53-58.
36. Johnson DE, Lo RK: Management of regional lymph nodes in penile carcinoma. Five-year results following therapeutic groin dissections. Urology 1984;24:308-311.
37. Bevan-Thomas R, Slaton JW, Pettaway CA: Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: The M.D. Anderson Cancer Center Experience. J Urol 2002;167:1638-1642.
38. Johnson DE, Lo RK: Complications of groin dissection in penile cancer. Experience with 101 lymphadenectomies. Urology 1984;24:312-314.
39. Broders AC: Squamous cell epithelioma of the skin. Ann Surg 1921;73:141-147.
40. McDougal WS: Carcinoma of the penis: Improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion. J Urol 1995;154:1364-1366.
41. Sanchez-Ortiz RF, Pettaway CA: Natural history, management, and surveillance of recurrent squamous cell penile carcinoma: A risk-based approach. Urol Clin North Am 2003;30:853-867.
42. Cubilla AL, Barreto J, Caballero C, et al.: Pathologic features of epidermoid carcinoma of the penis. A prospective study of 66 cases. Am J Surg Pathol 1993;17:753-763.
43. Darai E, Karaitianos I, Durand JC: Treatment of inguinal lymph nodes in cancer of the penis. Apropos of 85 cases treated at the Institut Curie. Ann Chir 1988;42:748-752.
44. Solsona E, Iborra I, Rubio J, et al.: Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001;165:1506-1509.
45. Heyns CF, van Vollenhoven P, Steenkamp JW, et al.: Carcinoma of the penis: Appraisal of a modified tumour-staging system. Br J Urol 1997;80:307-312.
46. Fraley EE, Zhang G, Sazama R, et al.: Cancer of the penis. Prognosis and treatment plans. Cancer 1985;55:1618-1624.
47. Theodorescu D, Russo P, Zhang ZF, et al.: Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol 1996;155:1626-1631.
48. Horenblas S: Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: The role and technique of lymph node dissection. BJU Int 2001;88:473-483.
49. Lopes A, Bezerra AL, Pinto CA, et al.: p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: Analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002;168:81-86.
50. Bezerra AL, Lopes A, Santiago GH, et al.: Human papillomavirus as a prognostic factor in carcinoma of the penis: Analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 2001;91:2315-2321.
51. Hall MC, Sanders JS, Vuitch F, et al.: Deoxyribonucleic acid flow cytometry and traditional pathologic variables in invasive penile carcinoma: Assessment of prognostic significance. Urology 1998;52:111-116.
52. 't Veer LJ, Dai H, van de Vijver MJ, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
53. Hall TB, Barton DP, Trott PA, et al.: The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients. Clin Radiol 2003;58:367-371.
54. Harisinghani MG, Barentsz J, Hahn PF, et al.: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-2499.
55. Catalona WJ: Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: Technique and preliminary results. J Urol 1988;140:306-310.
56. Coblentz TR, Theodorescu D: Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penis. J Urol 2002;168:1386-1389.
57. Lopes A, Rossi BM, Fonseca FP, et al.: Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer 1996;77:2099-2102.
58. Cabañas RM: An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
59. Perinetti E, Crane DB, Catalona WJ: Unreliability of sentinel lymph node biopsy for staging penile carcinoma. J Urol 1980;124:734-735.
60. Fowler JE, Jr.: Sentinel lymph node biopsy for staging penile cancer. Urology 1984;23:352-353.
61. Wespes E, Simon J, Schulman CC: Cabanas approach: Is sentinel node biopsy reliable for staging penile carcinoma? Urology 1986;28:278-279.
62. Pettaway CA, Pisters LL, Dinney CP, et al.: Sentinel lymph node dissection for penile carcinoma: The M. D. Anderson Cancer Center experience. J Urol 1995;154:1999-2003.
63. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
64. Kroon BK, Horenblas S, Estourgie SH, et al.: How to avoid false negative dynamic sentinel node procedures in penile carcinoma. J Urol 2004;171:2191-2194.
65. Tanis PJ, Lont AP, Meinhardt W, et al.: Dynamic sentinel node biopsy for penile cancer: Reliability of a staging technique. J Urol 2002;168:76-80.
66. Lont AP, Horenblas S, Tanis PJ, et al.: Management of clinically node negative penile carcinoma: Improved survival after the introduction of dynamic sentinel node biopsy. J Urol 2003;170:783-786.
67. Narayana AS, Olney LE, Loening SA, et al.: Carcinoma of the penis: Analysis of 219 cases. Cancer 1982;49:2185-2191.
68. Horenblas S: Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: The role and technique of lymph node dissection. BJU Int. 2001;88:473-483.
69. Hussein AM, Benedetto P, Sridhar KS: Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990;65:433-438.
70. Shammas FV, Ous S, Fossa SD: Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992;147:630-632.
71. Haas GP, Blumenstein BA, Gagliano RG, et al.: Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: A Southwest Oncology Group study. J Urol 1999;161:1823-1825.
72. Kattan J, Culine S, Droz JP, et al.: Penile cancer chemotherapy: Twelve years' experience at Institut Gustave-Roussy. Urology 1993;42:559-562.
73. Pedrick TJ, Wheeler W, Riemenschneider H: Combined modality therapy for locally advanced penile squamous cell carcinoma. Am J Clin Oncol 1993;16:501-505.
74. Palmieri G, Gridelli C, Vitale A, et al.: Contemporary chemotherapy and radiotherapy for inguinal metastases of carcinoma of the penis: A case report. Tumori 1988;74:585-586.
75. Modig H, Duchek M, Sjodin JG: Carcinoma of the penis. Treatment by surgery or combined bleomycin and radiation therapy. Acta Oncol 1993;32:653-655.
76. Villavicencio H, Rubio-Briones J, Regalado R, et al.: Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 1997;32:442-447.
77. Kamat MR, Kulkarni JN, Tongaonkar HB: Carcinoma of the penis: The Indian experience. J Surg Oncol 1993;52:50-55.
78. Ornellas AA, Seixas AL, de Moraes JR: Analyses of 200 lymphadenectomies in patients with penile carcinoma. J Urol 1991;146:330-332.